North America Pulmonary Devices Market Growth and Analysis by 2027

The North America pulmonary devices market is expected to reach US$ 16,637.44 million by 2027 from US$ 7,581.04 million in 2019; it is estimated to grow at a CAGR of 10.3% from 2020 to 2027.

Pulmonary or respiratory devices are used to remove mucus and secretions from the airways or the respiratory tract. These medical devices are focused on diagnosis, control, treatment, management, and evaluation of the problems associated with respiratory tract.

Manufacturers in the pulmonary devices market are ramping up their focus on the adoption of various strategies, such as product innovation, product launches, and approvals, as well as R&D investment for advancements in ventilators, along with merger and acquisition as their developmental strategies to maintain the competitive environment in the market.

For instance, in January 2020, Masimo Corporation acquired Connected Care Business from NantHealth (US). This acquisition will support Masimo to assist hospitals in providing constant care through connectivity, automation, and innovative noninvasive monitoring technologies. Similarly, in April 2019, Inogen, Inc. introduced the Inogen One G5 portable oxygen concentrator with the highest oxygen production capacity per pound of weight, amounting to 1,260 ml. In May 2020, Philips partnered with Masimo. This partnership was aimed at integrating Masimo’s measurement technologies into select intellivue MX-Series multi-parameter monitors to help clinicians examine ventilation status and cerebral oximetry. In March 2019, ResMed acquired HB Healthcare Safety, a provider of home-based medical equipment for sleep and respiratory care devices.

The impact of the COVID-19 crisis is expected to further accelerate the growth of the respiratory devices market in North America. In addition, the threat will have a lasting impact on governments and regulatory agencies in terms of future preparedness when it comes to the next pandemic. Today, government is playing catch-up, swiftly intervening in an attempt to create alliances with manufacturers to handle the COVID-19 threat. In addition, international regulatory agencies are considering accelerated approval of certain respiratory devices.

Mexico Pulmonary Devices Market, Revenue and Forecast to 2027 (US$ Mn)

NORTH AMERICA PULMONARY DEVICES MARKET SEGMENTATION

By Type

• Therapeutic Devices
• Consumables and Accessories
• Diagnostic Devices
• Monitoring Devices

By Application

• Chronic Obstructive Pulmonary Disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Others

By End User

• Hospitals
• Home Care Settings
• Ambulatory Care Centers

By Country

• US
• Canada
• Mexico

Company Profiles

• ResMed
• Masimo
• Invacare Corporation
• Koninklijke Philips N.V.
• Getinge AB

North America Pulmonary Devices Report Scope